Search research articles
Contact Us
Filters
Showing results (31-40 of 106) with videos related to
Page
of 11
Sort By:
Pharmacoeconomics
|
October 13, 2010
Cost effectiveness of pharmacogenomics: a critical and systematic review
William B Wong, Josh J Carlson, Rahber Thariani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 13, 2019
Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy
Gregory F Guzauskas, Anirban Basu, Josh J Carlson, et al.
Leukemia & Lymphoma
|
April 15, 2016
Indirect costs and workplace productivity loss associated with non-Hodgkin lymphoma
Justin S Yu, Ryan N Hansen, Adriana Valderrama, et al.
Pharmacoeconomics
|
September 7, 2019
Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study
Dean A Regier, David L Veenstra, Anirban Basu, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 30, 2020
The use of real-world evidence in ICER's scoping process and clinical evidence assessments
Boshen Jiao, David L Veenstra, Woojung Lee, et al.
Journal of Medical Economics
|
April 11, 2014
Targeted erlotinib for first-line treatment of advanced non-small cell lung cancer: a budget impact analysis
Preeti S Bajaj, David L Veenstra, Hans-Peter Goertz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer
Josh J Carlson, Louis P Garrison, Scott D Ramsey, et al.
Journal of Comparative Effectiveness Research
|
August 22, 2022
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic <i>NTRK</i> gene fusion cancers
Kangho Suh, Josh J Carlson, Fang Xia, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 26, 2005
Economic analyses of human genetics services: a systematic review
Josh J Carlson, Nora Beidler Henrikson, David L Veenstra, et al.
JCO Precision Oncology
|
March 28, 2025
Real-World Molecular Testing Rates and Patterns in Patients With Primary Advanced or Recurrent Endometrial Cancer in the United States
Yilin Chen, Solomon J Lubinga, Troy Williams, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 106) with videos related to
Sort By:
Page
of 11
Pharmacoeconomics
|
October 13, 2010
Cost effectiveness of pharmacogenomics: a critical and systematic review
William B Wong, Josh J Carlson, Rahber Thariani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 13, 2019
Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy
Gregory F Guzauskas, Anirban Basu, Josh J Carlson, et al.
Leukemia & Lymphoma
|
April 15, 2016
Indirect costs and workplace productivity loss associated with non-Hodgkin lymphoma
Justin S Yu, Ryan N Hansen, Adriana Valderrama, et al.
Pharmacoeconomics
|
September 7, 2019
Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study
Dean A Regier, David L Veenstra, Anirban Basu, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 30, 2020
The use of real-world evidence in ICER's scoping process and clinical evidence assessments
Boshen Jiao, David L Veenstra, Woojung Lee, et al.
Journal of Medical Economics
|
April 11, 2014
Targeted erlotinib for first-line treatment of advanced non-small cell lung cancer: a budget impact analysis
Preeti S Bajaj, David L Veenstra, Hans-Peter Goertz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer
Josh J Carlson, Louis P Garrison, Scott D Ramsey, et al.
Journal of Comparative Effectiveness Research
|
August 22, 2022
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic <i>NTRK</i> gene fusion cancers
Kangho Suh, Josh J Carlson, Fang Xia, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 26, 2005
Economic analyses of human genetics services: a systematic review
Josh J Carlson, Nora Beidler Henrikson, David L Veenstra, et al.
JCO Precision Oncology
|
March 28, 2025
Real-World Molecular Testing Rates and Patterns in Patients With Primary Advanced or Recurrent Endometrial Cancer in the United States
Yilin Chen, Solomon J Lubinga, Troy Williams, et al.
Page
of 11